Opiate and 5-HT2A receptors in alcohol drinking: Preference in HAD rats is inhibited by combination treatment with naltrexone and amperozide

Alcohol

Volumn 13, Issue 1, 1996, Pages 53-57

  Lankford, M F ^a   Myers, R D ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

5 HT2A receptors; Addiction; Alcohol intake; Amperozide; Drinking; Ethanol preference; HAD rats; Naltrexone; Opiate receptors; Serotonin

Indexed keywords

ANIMALIA;

AMPEROZIDE; NALTREXONE; OPIATE RECEPTOR; RECEPTOR SUBTYPE; SEROTONIN 2 RECEPTOR; NARCOTIC ANTAGONIST; PIPERAZINE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; DRUG INHIBITION; DRUG PREFERENCE; FLUID INTAKE; LIMBIC CORTEX; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; ANIMAL; DRUG ANTAGONISM; MALE; PHYSIOLOGY;

ALCOHOL DRINKING; ANIMALS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PIPERAZINES; RATS; RECEPTORS, OPIOID; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0029670948     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/0741-8329(95)02011-X     Document Type: Article

References (26)

1. Critcher, E. C.; Lin, C.; Patel, J.; Myers, R. D. Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone. Pharmacol. Biochem. Behav. 18:225-229; 1983.
2. De Cabo, C.; Colado, M. I.; Pujol, A.; Martin, M. I.; Viveros, M. P. Naltrexone administration effects on regional brain monoamines in developing rats. Brain Res. Bull. 34(4):395-406; 1994.
3. De Waele, J. P.; Gianoulakis, C. Enhanced activity of the brain beta-endorphin system by free-choice ethanol drinking in C57b1/ 6 but not DBA/2 mice. Eur. J. Pharmacol. 258(1-2): 119-129; 1994.
4. Froehlich, J. C.; Harts, J.; Lumeng, L.; Li, T. K. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol. Biochem. Behav. 35:385-390; 1990.
5. Grauer, S. M.; Tao, R.; Auerbach, S. Morphine induces an increase in extracellular serotonin in the rat diencephalon. Brain Res. 599:277-282; 1992.
6. Kornet, M.; Goosen, C.; Van Ree, J. M. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology (Berlin) 104:367-376; 1991.
7. Lankford, M. F.; Roscoe, A. K.; Pennington, S.; Myers, R. D. Drinking of high concentrations of ethanol vs. palatable fluids in alcohol-preferring (P) rats: Valid animal model of alcoholism. Alcohol 4:293-299; 1991.
8. 2 antagonist. Pharmacol. Biochem. Behav. 53:33-40, 1996.
9. Myers, R. D. Psychopharmacology of alcohol. Annu. Rev. Pharmacol. Toxicol. 18:125-144; 1978.
10. Myers, R. D. Isoquinolines, β-carbolines and alcohol drinking: Involvement of opioid and dopaminergic mechanisms. Experientia 45:436-443; 1989.
11. Myers, R. D. New drugs for the treatment of experimental alcoholism. Alcohol 11(6):439-451; 1994.
12. Myers, R. D.; Critcher, E. C. Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV. Pharmacol. Biochem. Behav. 16:827-836; 1982.
13. Myers, R. D.; Lankford, M. F. Suppression of alcohol preference in high drinking (HAD) rats: Action of amperozide vs. naltrexone. Neuropsychopharmacology, 1996.
14. Myers, R. D.; Quarfordt, S. D. Alcohol drinking attenuated by sertraline in rats with 6-OHDA or 5,7-DHT lesions of N. accumbens: A caloric response?. Pharmacol. Biochem. Behav. 40:923-928; 1991.
15. Myers, R. D.; Borg, S.; Mossberg, R. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol 3:383-388; 1986.
16. Myers, R. D.; Lankford, M.; Björk, A. Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide. Pharmacol. Biochem. Behav. 43:661-667; 1992.
17. 2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring (P) rats. Pharmacol. Biochem. Behav. 45(3):741-747; 1993.
18. 2 antagonist amperozide. Alcohol 10(2):117-125; 1993.
19. 32) infused into the hypothalamus of the rat. Brain Res. Bull. 37:237-245; 1995.
20. O'Brien, C. P. Treatment of alcoholism as a chronic disorder. Alcohol 11:433-437; 1994.
21. Sharma, T. R.; Chan, W. C.; Gintzler, A. R. Effect of chronic naltrexone administration and its withdrawal on the regional activity of neurons that contain norepinephrine, dopamine and serotonin. Brain Res. 442:379-386; 1988.
22. 2 antagonist FG5893. Alcohol 10:243-248; 1993.
23. Volpicelli, J. R.; Alterman, A. I.; Hayashida, M.; O'Brien, C. P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 49:876-880; 1992.
24. Volpicelli, J. R.; Watson, N.; King, A.; Sherman, C.; O'Brien, C. Effect of naltrexone on alcohol "high" in alcoholics. Am. J. Psychiatry 152:613-615; 1995.
25. Yoshimoto, K.; McBride, W. J.; Lumeng, L.; Li., T. K. Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats. Alcohol. Clin. Exp. Res. 16:781-785; 1992.
26. Yoshioka, M.; Matsumoto, M.; Togashi, H.; Smith, C. B.; Sato, H. Opioid receptor regulation of 5-hydroxytryptamine release from the rat hippocampus measured by in vivo microdialysis. Brain Res. 613:74-79; 1993.